ArticleJournal for immunotherapy of cancer2022

Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab.

Khalid Jazieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.